Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,002 | 470 | 99.9% |
| Education | $6.96 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,597 | 122 | $0 (2024) |
| ABBVIE INC. | $1,255 | 104 | $0 (2024) |
| Lilly USA, LLC | $858.53 | 59 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $558.43 | 33 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $450.98 | 17 | $0 (2023) |
| PFIZER INC. | $240.05 | 17 | $0 (2024) |
| Lundbeck LLC | $209.79 | 11 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $197.55 | 13 | $0 (2023) |
| Esperion Therapeutics, Inc. | $169.86 | 10 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $143.51 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,054 | 136 | Novo Nordisk Inc ($456.15) |
| 2023 | $1,679 | 120 | Novo Nordisk Inc ($398.58) |
| 2022 | $1,670 | 105 | Novo Nordisk Inc ($447.90) |
| 2021 | $1,607 | 110 | Lilly USA, LLC ($325.00) |
All Payment Transactions
471 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Diabetes | ||||||
| 12/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Obesity | ||||||
| 12/12/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: DIABETES | ||||||
| 12/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.94 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: Pulmonology | ||||||
| 10/31/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/29/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/24/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $11.59 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: VACCINES | ||||||
| 10/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: PAIN | ||||||
| 10/21/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $9.39 | General |
| 10/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $3.51 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.82 | General |
| Category: Diabetes | ||||||
| 10/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.69 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: DIABETES | ||||||
| 09/23/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Diabetes Care | ||||||
| 09/19/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: VACCINES | ||||||
| 09/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.60 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Pulmonology | ||||||
| 09/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | COSELA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 153 | 833 | $58,824 | $34,868 |
| 2022 | 5 | 113 | 143 | $17,805 | $8,663 |
| 2021 | 7 | 191 | 220 | $32,875 | $15,771 |
| 2020 | 7 | 355 | 427 | $68,132 | $26,202 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 88 | 757 | $48,448 | $29,231 | 60.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 32 | 43 | $6,966 | $3,295 | 47.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 11 | 11 | $1,925 | $1,176 | 61.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 11 | 11 | $935.00 | $833.91 | 89.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 11 | 11 | $550.00 | $332.64 | 60.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 37 | 59 | $3,776 | $2,529 | 67.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 31 | 37 | $5,994 | $2,378 | 39.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 18 | 18 | $3,150 | $1,996 | 63.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $3,010 | $1,200 | 39.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 15 | $1,875 | $559.91 | 29.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 62 | 86 | $13,932 | $6,356 | 45.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 35 | 35 | $6,125 | $3,974 | 64.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 38 | 38 | $8,238 | $3,174 | 38.5% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 16 | 16 | $1,360 | $1,057 | 77.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 15 | $1,860 | $912.46 | 49.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 16 | 16 | $800.00 | $265.44 | 33.2% |
| 81003 | Automated urinalysis test | Office | 2021 | 11 | 14 | $560.00 | $31.50 | 5.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 146 | 214 | $34,668 | $12,444 | 35.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 76 | 76 | $18,924 | $6,835 | 36.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 37 | 37 | $6,475 | $3,598 | 55.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 46 | 47 | $5,170 | $2,171 | 42.0% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2020 | 13 | 13 | $1,105 | $793.00 | 71.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 19 | 19 | $950.00 | $314.50 | 33.1% |
| 81003 | Automated urinalysis test | Office | 2020 | 18 | 21 | $840.00 | $46.75 | 5.6% |
About Spring Cramer, APRN
Spring Cramer, APRN is a Family healthcare provider based in Lake City, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2009. The National Provider Identifier (NPI) number assigned to this provider is 1902030596.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Spring Cramer, APRN has received a total of $7,009 in payments from pharmaceutical and medical device companies, with $2,054 received in 2024. These payments were reported across 471 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($7,002).
As a Medicare-enrolled provider, Cramer has provided services to 812 Medicare beneficiaries, totaling 1,623 services with total Medicare billing of $85,505. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Lake City, FL
- Active Since 05/11/2009
- Last Updated 05/16/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1902030596
Products in Payments
- JARDIANCE (Drug) $659.94
- Ozempic (Drug) $547.57
- UBRELVY (Drug) $523.96
- VRAYLAR (Drug) $515.22
- Rybelsus (Drug) $472.88
- FARXIGA (Drug) $310.66
- TRULICITY (Drug) $277.46
- Wegovy (Drug) $277.46
- REXULTI (Drug) $263.51
- NURTEC ODT (Drug) $227.27
- Kerendia (Drug) $197.55
- MOUNJARO (Drug) $171.86
- QULIPTA (Drug) $152.08
- NEXLETOL (Drug) $148.14
- EMGALITY (Drug) $147.59
- VOQUEZNA (Drug) $143.51
- LEQVIO (Drug) $112.75
- REMICADE (Biological) $97.38
- FASENRA (Biological) $89.39
- Saxenda (Drug) $89.11
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Lake City
Taily Alonso, Aprn, APRN
Family — Payments: $10,522
Hillary Bailey, Dnp, Aprn, DNP, APRN
Family — Payments: $7,643
Camilla Pace, Fnp, FNP
Family — Payments: $6,744
Elaina Williamson, Arnp, ARNP
Family — Payments: $3,620
Beth Henderson, Aprn, APRN
Family — Payments: $3,539
Dr. Samantha Smythe, Aprn, APRN
Family — Payments: $2,762